Furthermore, the histone deacetylase (HDAC) SIRT1, by virtue of its role in inflammatory responses, adipokine secretion and its interaction with the insulin signaling pathway, is suggested to have therapeutic benefit in treating insulin resistance [11]. This evidence concerns the gene INS and Insulin resistance.